tiprankstipranks
Enveric Biosciences (ENVB)
NASDAQ:ENVB
US Market

Enveric Biosciences (ENVB) Financial Statements

570 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently $3.70M. The company's EPS TTM is $0.85; its P/E ratio is -0.10; Enveric Biosciences is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -200.86K$ -337.49K$ -408.03K$ -435.20K$ -681.61K
Operating Income$ -8.77M$ -9.63M$ -16.45M$ -19.96M$ -25.94M
EBITDA$ -8.57M$ -9.23M$ -16.85M$ -19.52M$ -55.74M
Net Income$ -12.13M$ -9.57M-$ -18.50M$ -48.98M
Balance Sheet
Cash & Short-Term Investments$ 4.68M$ 2.24M$ 2.29M$ 17.72M$ 17.36M
Total Assets$ 5.10M$ 3.08M$ 4.30M$ 19.55M$ 26.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 63.82K$ 176.30K
Net Debt$ -4.68M$ -2.24M$ -2.29M$ -17.66M$ -17.18M
Total Liabilities$ 918.40K$ 1.49M$ 2.34M$ 4.00M$ 4.41M
Stockholders' Equity$ 4.18M$ 1.59M$ 1.96M$ 14.67M$ 22.31M
Cash Flow
Free Cash Flow$ -8.14M$ -7.73M$ -14.10M$ -17.73M$ -12.32M
Operating Cash Flow$ -8.14M$ -7.73M$ -14.09M$ -17.15M$ -11.46M
Investing Cash Flow$ 0.00$ 0.00$ 11.67K$ -584.16K$ 2.19M
Financing Cash Flow$ 10.58M$ 7.67M$ -1.34M$ 18.18M$ 24.90M
Currency in USD

Enveric Biosciences Earnings and Revenue History

Enveric Biosciences Debt to Assets

Enveric Biosciences Cash Flow

Enveric Biosciences Forecast EPS vs Actual EPS